Literature DB >> 27126681

Nano carriers for drug transport across the blood-brain barrier.

Xinming Li1,2, John Tsibouklis2, Tingting Weng3, Buning Zhang1, Guoqiang Yin1, Guangzhu Feng1, Yingde Cui1, Irina N Savina4, Lyuba I Mikhalovska4, Susan R Sandeman4, Carol A Howel4, Sergey V Mikhalovsky4,5.   

Abstract

Effective therapy lies in achieving a therapeutic amount of drug to the proper site in the body and then maintaining the desired drug concentration for a sufficient time interval to be clinically effective for treatment. The blood-brain barrier (BBB) hinders most drugs from entering the central nervous system (CNS) from the blood stream, leading to the difficulty of delivering drugs to the brain via the circulatory system for the treatment, diagnosis and prevention of brain diseases. Several brain drug delivery approaches have been developed, such as intracerebral and intracerebroventricular administration, intranasal delivery and blood-to-brain delivery, as a result of transient BBB disruption induced by biological, chemical or physical stimuli such as zonula occludens toxin, mannitol, magnetic heating and ultrasound, but these approaches showed disadvantages of being dangerous, high cost and unsuitability for most brain diseases and drugs. The strategy of vector-mediated blood-to-brain delivery, which involves improving BBB permeability of the drug-carrier conjugate, can minimize side effects, such as being submicrometre objects that behave as a whole unit in terms of their transport and properties, nanomaterials, are promising carrier vehicles for direct drug transport across the intact BBB as a result of their potential to enter the brain capillary endothelial cells by means of normal endocytosis and transcytosis due to their small size, as well as their possibility of being functionalized with multiple copies of the drug molecule of interest. This review provids a concise discussion of nano carriers for drug transport across the intact BBB, various forms of nanomaterials including inorganic/solid lipid/polymeric nanoparticles, nanoemulsions, quantum dots, nanogels, liposomes, micelles, dendrimers, polymersomes and exosomes are critically evaluated, their mechanisms for drug transport across the BBB are reviewed, and the future directions of this area are fully discussed.

Entities:  

Keywords:  Blood–brain barrier; drug delivery; nanomaterials

Mesh:

Substances:

Year:  2016        PMID: 27126681     DOI: 10.1080/1061186X.2016.1184272

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  52 in total

1.  Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.

Authors:  Timothy M Brenza; Benjamin W Schlichtmann; Biju Bhargavan; Julia E Vela Ramirez; Rainie D Nelson; Matthew G Panthani; JoEllyn M McMillan; Balaraman Kalyanaraman; Howard E Gendelman; Vellareddy Anantharam; Anumantha G Kanthasamy; Surya K Mallapragada; Balaji Narasimhan; Georgette D Kanmogne
Journal:  J Biomed Mater Res A       Date:  2018-10-26       Impact factor: 4.396

2.  A microfluidic model of the blood-brain barrier to study permeabilization by pulsed electric fields.

Authors:  M Bonakdar; P M Graybill; R V Davalos
Journal:  RSC Adv       Date:  2017-09-05       Impact factor: 3.361

3.  Intranasal Zotepine Nanosuspension: intended for improved brain distribution in rats.

Authors:  Sravanthi Reddy Pailla; Sreekanth Talluri; Nagarjun Rangaraj; Ramdas Ramavath; Veerabhadra Swamy Challa; Nandkumar Doijad; Sunitha Sampathi
Journal:  Daru       Date:  2019-06-29       Impact factor: 3.117

Review 4.  Technology and Dementia: The Future is Now.

Authors:  Arlene J Astell; Nicole Bouranis; Jesse Hoey; Allison Lindauer; Alex Mihailidis; Chris Nugent; Julie M Robillard
Journal:  Dement Geriatr Cogn Disord       Date:  2019-06-27       Impact factor: 2.959

Review 5.  Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?

Authors:  Yuying Guo; Dongsheng Hu; Lu Lian; Linna Zhao; Mingli Li; Huijing Bao; Shixin Xu
Journal:  Stem Cell Rev Rep       Date:  2022-09-29       Impact factor: 6.692

Review 6.  Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.

Authors:  Kerui Wu; Fei Xing; Shih-Ying Wu; Kounosuke Watabe
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-10-18       Impact factor: 10.680

Review 7.  Nano-based drug delivery system: a smart alternative towards eradication of viral sanctuaries in management of NeuroAIDS.

Authors:  Nidhi Aggarwal; Bushra Nabi; Sumit Aggarwal; Sanjula Baboota; Javed Ali
Journal:  Drug Deliv Transl Res       Date:  2021-01-23       Impact factor: 4.617

8.  Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity.

Authors:  Duhyeong Hwang; Taylor Dismuke; Andrey Tikunov; Elias P Rosen; John R Kagel; Jacob D Ramsey; Chaemin Lim; William Zamboni; Alexander V Kabanov; Timothy R Gershon; Marina Sokolsky-Papkov PhD
Journal:  Nanomedicine       Date:  2020-11-28       Impact factor: 5.307

Review 9.  Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets.

Authors:  Sreeja Lakshmi; Musthafa Mohamed Essa; Richard E Hartman; Gilles J Guillemin; Sureshkumar Sivan; Preetham Elumalai
Journal:  Neurochem Res       Date:  2020-08-25       Impact factor: 3.996

Review 10.  Remodelling and Treatment of the Blood-Brain Barrier in Glioma.

Authors:  Yihao Wang; Fangcheng Zhang; Nanxiang Xiong; Hao Xu; Songshan Chai; Haofei Wang; Jiajing Wang; Hongyang Zhao; Xiaobing Jiang; Peng Fu; Wei Xiang
Journal:  Cancer Manag Res       Date:  2021-05-27       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.